Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance

AM Schram, MT Chang, P Jonsson… - Nature reviews Clinical …, 2017 - nature.com
Structural gene rearrangements resulting in gene fusions are frequent events in solid
tumours. The identification of certain activating fusions can aid in the diagnosis and effective …

Children's Oncology Group's 2013 blueprint for research: bone tumors

R Gorlick, K Janeway, S Lessnick… - Pediatric blood & …, 2013 - Wiley Online Library
In the US, approximately 650 children are diagnosed with osteosarcoma and Ewing
sarcoma (ES) each year. Five‐year survival ranges from 65% to 75% for localized disease …

Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth

S Sankar, ER Theisen, J Bearss, T Mulvihill… - Clinical cancer …, 2014 - AACR
Purpose: Ewing sarcoma is a pediatric bone tumor that absolutely relies on the
transcriptional activity of the EWS/ETS family of fusion oncoproteins. While the most common …

Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics

VH Le, M Inai, RM Williams, T Kan - Natural product reports, 2015 - pubs.rsc.org
Covering: up to 2014 The ecteinascidin family comprises a number of biologically active
compounds, containing two to three tetrahydroisoquinoline subunits. Although isolated from …

Recent advances in the molecular pathogenesis of Ewing's sarcoma

EC Toomey, JD Schiffman, SL Lessnick - Oncogene, 2010 - nature.com
Tumor development is a complex process resulting from interplay between mutations in
oncogenes and tumor suppressors, host susceptibility factors, and cellular context. Great …

NKX2. 2 is a useful immunohistochemical marker for Ewing sarcoma

A Yoshida, S Sekine, K Tsuta… - The American journal …, 2012 - journals.lww.com
Ewing sarcoma is a high-grade round cell sarcoma that affects bones and soft tissues in
children and young adults. Its diagnosis can be challenging, and the differential diagnoses …

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

S Sankar, R Bell, B Stephens, R Zhuo, S Sharma… - Oncogene, 2013 - nature.com
Ewing sarcoma provides an important model for transcription-factor-mediated oncogenic
transformation because of its reliance on the ETS-type fusion oncoprotein EWS/FLI. EWS/FLI …

Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets

SL Lessnick, M Ladanyi - Annual Review of Pathology …, 2012 - annualreviews.org
Approximately one-third of sarcomas contain specific translocations. Ewing sarcoma is the
prototypical member of this group of sarcomas; it was the first to be recognized …

IGF1R-and ROR1-specific CAR T cells as a potential therapy for high risk sarcomas

X Huang, H Park, J Greene, J Pao, E Mulvey, SX Zhou… - PloS one, 2015 - journals.plos.org
Patients with metastatic or recurrent and refractory sarcomas have a dismal prognosis.
Therefore, new targeted therapies are urgently needed. This study was designed to evaluate …

Dr. Jekyll and Mr. Hyde: the two faces of the FUS/EWS/TAF15 protein family

H Kovar - Sarcoma, 2011 - Wiley Online Library
FUS, EWS, and TAF15 form the FET family of RNA‐binding proteins whose genes are found
rearranged with various transcription factor genes predominantly in sarcomas and in rare …